147 Results
Guidelines and Advice
Status: Current
ID: C50-CIDAP-1
ID: C50-CIDAP-1
Mar 2024
Drug
Mar 2024
Guidelines and Advice
Status: In-Review
ID: GL END 3-23
Version: N/A
ID: GL END 3-23
Version: N/A
Oct 2021